Log in or Register for enhanced features | Forgotten Password?
White Papers | Suppliers | Events | Report Store | Companies | Dining Club | Medical Devices
Automation
IT & Software
Return to: PBR Home | Automation | IT & Software | News
Search Refinements

IT & Software News

View news from other Pharmaceutical sectors:
76-90 of 1494 results
Teva announces initiation of NDA and positive results from second human abuse liability study for CEP-33237
Teva Pharmaceutical Industries announced the initiation of a rolling New Drug Application (NDA) submission to the US Food and Drug Administration for hydrocodone bitartrate extended-release tablets designed with Teva’s proprietary technology providing potential abuse-deterrent properties (CEP-33237) as allowed for fast track designated products.
Automation > IT & Software > News
Salix, Cosmo Technologies agree to terminate merger agreement
By PBR Staff Writer
Salix Pharmaceuticals and Cosmo Pharmaceuticals have agreed to terminate their previously-announced merger agreement.
Automation > IT & Software > News
Histogenics, Intrexon enter exclusive channel collaboration for cartilage repair therapies
Histogenics, a regenerative medicine company focused on developing and commercializing products in the musculoskeletal space, and Intrexon (XON), a leader in synthetic biology, today announced the formation of an Exclusive Channel Collaboration (ECC) for the generation of allogeneic chondrocyte cell therapeutics to repair damaged articular hyaline cartilage in humans.
Automation > IT & Software > News
Argos plans for new manufacturing facility in Durham, North Carolina
Argos Therapeutics (ARGS), a biopharmaceutical company focused on the development and commercialization of fully personalized immunotherapies for the treatment of cancer and infectious diseases using its Arcelis technology platform, has announced plans for development of a state of the art biomanufacturing facility in the Research Triangle Park area in Durham, North Carolina.
Automation > IT & Software > News
Quest PharmaTech, Bioceltran ink licence deal for photodynamic therapy technology
By PBR Staff Writer
Quest PharmaTech has agreed to license its photodynamic therapy (PDT) technology to South Korea-based firm Bioceltran in return for up-front license fees, milestone payments and royalties on future product sales.
Automation > IT & Software > News
Cellular Biomedicine completes acquisition of Agreen Biotech
Cellular Biomedicine Group (CBMG), a biomedicine firm engaged in the development of new treatments for degenerative and cancerous diseases, has announced it has completed the previously announced acquisition of privately held Agreen Biotech and its founder's US patent.
Automation > IT & Software > News
TherapeuticsMD starts Phase III trial of TX-004HR to treat VVA
By PBR Staff Writer
TherapeuticsMD, a US-based women’s healthcare firm, has started patient enrollment in its Phase III clinical trial of TX-004HR (VagiCap) to treat painful intercourse (dyspareunia), a symptom of vulvar and vaginal atrophy (VVA), due to menopause.
Automation > IT & Software > News
Mymetics' HIV vaccine candidate gets funding to begin study at Texas Biomedical Research Institute
Mymetics a pioneer in the research and development of virosome-based vaccines to prevent transmission of human infectious diseases across mucosal membranes, has announced that its innovative HIV vaccine candidate will enter a new preclinical trial to confirm excellent results obtained in a previous trial.
Automation > IT & Software > News
Adaptimmune secures $104m in series A financing
Adaptimmune Limited, a leading biotechnology company focused on the use of T-cell therapy to treat cancer and infectious disease, has announced the completion of a $104m Series A financing round.
Automation > IT & Software > News
ImmunoCellular, Caltech enter licensing deal for new antigen-specific T-cell technology
By PBR Staff Writer
ImmunoCellular Therapeutics has entered into a licensing agreement with the California Institute of Technology (Caltech) for exclusive rights of new technology to develop certain antigen specific T-cell immunotherapies to treat cancer.
Automation > IT & Software > News
Inovio's Ebola vaccine moving into human trial with GeneOne life science
Inovio Pharmaceuticals has announced that it will advance its DNA vaccine for Ebola into a phase I clinical trial in a collaboration with GeneOne Life Science, an international DNA vaccine manufacturer in which Inovio holds a minority interest.
Automation > IT & Software > News
iCeutica receives key patent for soluMatrix fine particle technology platform
iCeutica has announced that its wholly owned subsidiary has been awarded a key patent for its SoluMatrix Fine Particle Technology platform by the US Patent and Trademark Office (USPTO).
Automation > IT & Software > News
Clinical Ink's eSouce platform selected to power global CNS study
Clinical Ink, an innovation-driven eSource solutions company, has announced that its SureSource platform was selected to capture the critical efficacy data for a global Phase II central nervous system (CNS) study.
Automation > IT & Software > News
Soligenix secures NIAID contract to develop heat stable RiVax vaccine
By PBR Staff Writer
US-based biopharmaceutical firm Soligenix has received a $24.7m contract from the US Department of Health and Human Service's National Institutes of Health (NIH) to develop Heat Stable RiVax vaccine.
Automation > IT & Software > News
biOasis begins MPS II trial with Lysosomal storage disease expert Dr. Maurizio Scarpa and The Brains for Brain Foundation
biOasis Technologies, the pioneering biopharmaceutical company focused on the delivery of therapeutic drugs across the blood-brain barrier (BBB), has announced a study to investigate the ability of its Transcend BBB transport platform technologies to deliver to the Central Nervous System of a knockout animal model, the therapeutic enzyme required to correct the neurological disorder, MPS II, or Hunter Syndrome.
Automation > IT & Software > News
76-90 of 1494 results